LDS/Medical Tests/Tempus PurIST℠ Pancreatic Cancer Test

Tempus PurIST℠ Pancreatic Cancer Test

Pancreatic cancer is the third leading cause of cancer-related deaths worldwide, with pancreatic ductal adenocarcinoma (PDAC) as the predominant histologic subtype. Despite advances in imaging and chemotherapy, effective biomarkers for guiding treatment remain limited.

The Tempus PurIST℠ (Purity Independent Subtyping of Tumors) test classifies patients with unresectable stage III or stage IV PDAC into molecular subtypes using RNA sequencing with an AI-driven algorithm. The test identifies two clinically relevant PDAC subtypes:

  • Classical subtype – associated with better prognosis and improved median overall survival, particularly when treated with first-line FOLFIRINOX.
  • Basal subtype – associated with more aggressive biology, poorer prognosis, and reduced benefit from FOLFIRINOX.

This classification provides actionable insights to personalize therapy and optimize outcomes for patients with advanced pancreatic cancer.

  • Enables tumor subtyping to guide therapy selection
  • Provides prognostic information to predict disease aggressiveness and survival
  • Assists in tailoring first-line chemotherapy strategies, especially FOLFIRINOX

Reported as the probability of predicted molecular subtype (Classical vs. Basal).

Classical subtype: associated with better response and survival outcomes. 

Basal subtype: associated with poorer outcomes, prompting consideration of alternative therapies.

Not applicable (reported as subtype probability)

Next-generation sequencing (NGS) with AI-based algorithmic analysis of whole-transcriptome RNA sequencing data.

Whole blood, EDTA.

Stability

  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: 30 days
Amylase, lipase, CA19.9, PancreaSeq.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login